» Articles » PMID: 29644236

Hypertrophic Cardiomyopathy with a Large Apical Ventricular Aneurysm and Mural Thrombus

Overview
Date 2018 Apr 13
PMID 29644236
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertrophic cardiomyopathy (HCM) is characterized by increased left ventricular wall thickness in the absence of any other identifiable cause of thickness. It predisposes the patient to increased risk of sudden cardiac death (SCD) due to fatal arrhythmias. Approximately 2% of the HCM patients have left ventricular apical aneurysm. CMR imaging is better in identifying this apical aneurysm as compared to echocardiogram. This apical aneurysm, which can be akinetic or dyskinetic, increases the risk of disease-related adverse events as compared to general HCM. These adverse disease-related events include SCD, thromboembolism, and symptoms of heart failure. We report a rare case of hypertrophic cardiomyopathy in association with Williams-Beuren Syndrome. On CMR imaging, patient was found to have a large apical aneurysm and mid-ventricular obstruction with underlying thrombus. He was started on oral anticoagulation, and ICD was recommended.

Citing Articles

Prediction of diagnostic gene biomarkers for hypertrophic cardiomyopathy by integrated machine learning.

You H, Dong M J Int Med Res. 2023; 51(11):3000605231213781.

PMID: 38006610 PMC: 10683566. DOI: 10.1177/03000605231213781.


An Atypical Non-Cardiac Presentation of Hypertrophic Cardiomyopathy.

Alexandre A, Roque C, Sa I, Silveira J, Torres S Arq Bras Cardiol. 2023; 120(6):e20220933.

PMID: 37377257 PMC: 10344080. DOI: 10.36660/abc.20220933.


Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.

Habib M, Hoss S, Rakowski H Curr Cardiol Rep. 2019; 21(8):75.

PMID: 31243594 DOI: 10.1007/s11886-019-1173-1.

References
1.
Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M . 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 124(24):2761-96. DOI: 10.1161/CIR.0b013e318223e230. View

2.
Adabag A, Maron B, Appelbaum E, Harrigan C, Buros J, Gibson C . Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008; 51(14):1369-74. DOI: 10.1016/j.jacc.2007.11.071. View

3.
Elliott P, Gimeno J, Thaman R, Shah J, Ward D, Dickie S . Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart. 2005; 92(6):785-91. PMC: 1860645. DOI: 10.1136/hrt.2005.068577. View

4.
Maron M, Finley J, Bos J, Hauser T, Manning W, Haas T . Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation. 2008; 118(15):1541-9. DOI: 10.1161/CIRCULATIONAHA.108.781401. View

5.
Mauser W, Bonnemeier H . Cardiomyopathy and sudden cardiac death in Williams-Beuren-syndrome. Int J Cardiol. 2011; 156(3):e53-4. DOI: 10.1016/j.ijcard.2011.08.044. View